Ip Share Discussion Threads

[p1nkfish] 27/8/2017 09:33

Might de shorted with no declaration?
Some shenanigans.

[nav_mike] 26/8/2017 22:35

Been watching these for about a week....they seem to regularly take a dive in the afternoon.

Any US influence on these?

[p1nkfish] 26/8/2017 22:11

Nothing g to write home about - 1.3% short interest in ipo with Mangrove Partner's Master Fund open for a while, if the FCA data is accurate.

[p1nkfish] 26/8/2017 15:10

Suspect there's some shorting in place.

[davr0s] 25/8/2017 17:37

Not sure - it's in danger of making multi year lows. Can't believe those that stumped up 140 in fund raising can be that pleased

[p1nkfish] 24/8/2017 21:53

Agreed Davros but others in the same boat so it's not IPO specific.
Frustrating.

[davr0s] 24/8/2017 19:19

This ain't really going to plan - thankfully I got out some time back

[p1nkfish] 22/8/2017 07:16

Like the look of the Itesso news.
Worth reading up on them.

[p1nkfish] 17/8/2017 07:12

Chinese blocked from joining, £23M won't be raised but carry on with IVO bid as before.
Onward!

[swedeee] 16/8/2017 15:16

any reasons for the large swings in sp?

[sarpanch] 21/7/2017 10:18

Five investment analysts have rated the stock with a buy rating. More confidence from the market. Lets see if it can move towards 145 today.

[sarpanch] 18/7/2017 23:11

Finally a good news we have been waiting for -
The company said pretax profit for the period was GBP18.2 million, swinging from a pretax loss of GBP34.3 million the year previously. This was due to a change in the fair value of its equity and debt investments to GBP28.5 million, from a fair value loss of GBP24.5 million the year before.

Licensing income was nearly tripled to GBP2.6 million from GBP900,000 the year before. The fair value of its portfolio also increased to GBP663.0 million from GBP525.7 million year-on-year.

[sarpanch] 18/7/2017 20:12

IP group confirmed a better offer for Touchstone. Each Touchstone shareholder would be entitled to receive 2.2178 new IP Group shares for each Touchstone share.

Also, Imerial college supports this take over who got 15.3% touchstone share capital.

[p1nkfish] 14/7/2017 07:42

Ivo NAV now higher than current offer and further events might straddle year end but not massive impact. Something has to move or offer could fail. Snapping up ivo below NAV would be a coup but what chance?

Big holders won't suffer (they hold both) but ipo smaller holders will be diluted further in enlarged group with higher % going to ivo. Just mht.

[gilotron] 01/7/2017 15:10

I was thumbing through the annual report trying to find out what their annual costs are each year, seems like 20 odd mill. This debt they took on this year is it just a share issue or are they going to have to pay interest on it? Always difficult to value companies that aren't actually making a profit..

[bamboo2] 28/6/2017 14:41

Confirmed Head and Shoulders pattern is currently targeting 120-125 depending on neckline position. Probably only an intraday visit to these prices.

Could snap back up anytime once sentiment changes.

[seans66] 28/6/2017 14:33

Mistimed my top up very badly yesterday.

[p1nkfish] 21/6/2017 23:47

Still have an eye on UBI. Volume peaked up today as someone sold a couple 100k then price recovered. Pretty sure new management will get the 70p+ share price to get their £'s.

[p1nkfish] 21/6/2017 23:40

Yes.

If bought as a med-long term hold I wouldn't sweat it too much anyway.
Hold nose, buy, forget, come back in 3-5 years.
Combined portfolio is very impressive.

I hold IPO and IVO and have partaken to maintain % of increased shares in issue. Also added to IVO sub 293p, only a few added though.

The portfolio will have some dogs in it but some very big gems too.

A change in sentiment to bio-tech will give it a fillip. Only a matter of time.

[bamboo2] 21/6/2017 22:16

Hi pinkfish, thanks for taking the trouble to reply so comprehensively. That's precisely the info I was after.

So the combined group will have only a small premium at today's prices.

Another concern is the spending on Directors salaries, bonuses, free shares etc, but I guess there will be little we can do about that.

[p1nkfish] 21/6/2017 22:05

90% of ivo portfolio value is unlisted.

Ivo half year, end of Jan 2017 - "Net assets increased to £472.4 million (FY 2016: £455.9 million), NAV per share £2.93"

Original ipo approach was at 307p, could rise to 320p if ipo share price rises to 148p due to 2.1575 conversion ratio. MOST RECENT price equivalent was £2.89p per ivo share - bit of a bargain imho given the potential.

Ipo chanced their arm with 3 major ivo shareholders on side. Makes a lot of sense.

[p1nkfish] 21/6/2017 21:33

Not much. The NAV of ivo is heavily dependent on non-listed of which there is a bio-tech tilt that is out of favour.

Depending on the ipo share price the original offer come to 307p in ipo shares vs an ivo share price of about 284p (approx) at the time but I can't remember the ivo nav at that date.

Ipo + ivo makes a lot of sense if they can manage what will be a behemoth in pre-ipo new tech.

I bought ivo as I thought it excessively punished when circassia phase iii trial failed. The fact it was IVO'S largest holding appeared poor judgement on their part but recoverable.

Given bio-tech is out of favour, and ivo had a hit due to circassia, I think ipo have been very opportunistic and will pick up a good exposure to new future growth holdings and dilute their own excess reliance on Oxford Nano. There should also be overhead reductions. I don't see the price paid as excessive and its in ipo stock.

Can they manage the behemoth?

It requires much patience as I don't see this showing good value for a few years either combined or separate but handle right it has multi-bagger potential imho. The future is in that combined portfolio - how we power our lives, how long we live and how we minimise environmental impact. Well worth buying and holding for 5-10.

[bamboo2] 21/6/2017 21:13

Hi pinkfish, I haven't been following very closely. Is IPO Group paying a premium for IVO?

IPO looks more appealing to me without a premium, until such time as the businesses are successful in their own right